Stock A086450 DONGKOOK PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News DongKook Pharmaceutical Co., Ltd.

Equities

A086450

KR7086450004

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 24/06/2024 am IST 		5-day change 1st Jan Change
17,590 KRW -1.01% Intraday chart for DongKook Pharmaceutical Co., Ltd. -3.77% +8.85%
16/05 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/03 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine
MT
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
YJM Games Co., Ltd. announced that it has received KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd.
CI
YJM Games Co., Ltd. announced that it expects to receive KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd., and other investors
CI
Hanchang Corporation announced that it has received KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation
CI
Hanchang Corporation announced that it expects to receive KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation
CI
DongKook Pharmaceutical Co., Ltd. announced that it has received KRW 10.0000516 billion in funding
CI
DongKook Pharmaceutical Co., Ltd. announced that it expects to receive KRW 10.0000516 billion in funding
CI
GS Instruments Co. Ltd. announced that it has received KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.
CI
GS Instruments Co. Ltd. announced that it expects to receive KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.
CI
DONGKOOK Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 13, 2015 has expired.
CI
DONGKOOK Pharmaceutical Co., Ltd.(KOSDAQ:A086450) added to Russell Global Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A086450 Stock
  4. News DongKook Pharmaceutical Co., Ltd.